Study Reveals Effectivity Of Hydroxychloroquine At Preventing COVID-19

A certain study revealed the effectivity of Hydroxychloroquine at preventing COVID-19.

A study from the team of researchers at the University of Minnesota revealed the effectivity of Hydroxychloroquine at preventing COVID-19.

This, as the said study was published in the New England Journal of Medicine. It revealed on Wednesday that by taking Hydroxychloroquine after being exposed to a person who has a coronavirus disease didn’t help prevent COVID-19 in a “statistically meaningful way”.

Previously, the Hydroxychloroquine had been promoted by US President Donald Trump and said that he took the said medicine as “a prophylaxis” against COVID-19. He even sent two million doses of Hydroxychloroquine to Brazil.

READ ALSO: US Delivers 2 Million Doses Of ‘Unproven’ Antiviral Drug To Brazil

However, an experiment involving 821 adults across Canada and the United States showed that the said medicine didn’t work significantly better than a placebo.

Hydroxychloroquine Tablets | Photo from AFP News

Researchers enrolled its respondents — 821 adults who had close contact with a COVID-19 patient for more than 10 minutes at a distance of two meters or less. 719 of the respondents were considered to have had “high-risk” exposure just because they didn’t wear a face mask and an eye shield at that time, while the remaining 102 were “moderate-risk” just because they covered their face yet they didn’t wear goggles.

All respondents were randomly assigned to receive either a placebo or hydroxychloroquine within four days. The side effects were “more common” with hydroxychloroquine compared with the placebo, yet no serious adverse reactions were reported.

Researchers said that the randomized trial “did not demonstrate a significant benefit” of hydroxychloroquine as a “postexposure prophylaxis” for coronavirus disease 2019 or COVID-19.

Meanwhile, according to Martin Landray, the University of Oxford’s professor of medicine and epidemiology, more research was needed in order to know whether the said medicine might have a moderately-positive effect as the said study was “too small to be definitive”, adding that the results would make it “very unlikely” that there’s a large effect yet can’t rule out a “more modest difference” which would be very valuable.

What can you say about this? Let us know!

For more news and updates, follow Philippine Newspaper on Facebook!

READ ALSO | DOH: PH To Halt The Use Of Hydroxychloroquine For COVID-19 Patients

Leave a Comment